Last modified: Monday, October 19, 2009
Indiana Life Sciences Collaboration Conference returns to Cook Inc. for Nov. 13 event
American Institute for Public Policy Research scholar to keynote program
FOR IMMEDIATE RELEASE
Oct. 19, 2009
EDITORS: A complete program schedule, links to the participants' biographies and directions are available at https://kelley.iu.edu/CBLS/conferences/page16783.html. Media interested in attending need to contact George Vlahakis of IU's Office of University Communications at 812-855-0846 or email@example.com.
BLOOMINGTON, Ind. -- The successful Indiana Life Sciences Collaboration Conference Series will return to the Bloomington headquarters of one of the state's oldest and most successful companies, Cook Medical, for the second of its 2009-10 seminars on Friday, Nov. 13.
The conference will focus on the topic of comparative effectiveness research, which provides and disseminates information on the relative strengths and weaknesses of various medical therapies. As part of the nearly $800 billion federal program created through the American Recovery and Reinvestment Act, $1.1 billion has been allocated for comparative effectiveness research.
"It has the potential to create major changes for all organizations in the life sciences value chain -- manufacturers of drugs and devices, suppliers and service providers, payers, hospitals, physicians and patients," said Larry Davidson, founding director of the Center for the Business of Life Sciences and the W. Michael and William D. Wells Life Sciences Faculty Fellow in the Indiana University Kelley School of Business.
The conference will examine the policy and implementation issues relating to comparative effectiveness research, including how Indiana life sciences firms will be impacted and may take advantage of it. Other policy issues that to be discussed include who pays for it, and how the United States can learn from similar research activities in other countries.
The conference will take place from 8 a.m. to 3:15 p.m. at the Cook Medical World Headquarters, 750 Daniels Way, in Bloomington. The registration fee for the conference is $70. Other events in the series will take place Feb. 26 and May 14 in Indianapolis.
Registration is available online at https://www.kelley.iu.edu/CBLS/conferences/registration/page16551.html or by contacting Roxie Glaze at the Kelley School at 812-855-9210 or firstname.lastname@example.org.
The Indiana Life Sciences Collaboration Conference Series is presented by the Indiana University Kelley School of Business and its Center for the Business of Life Sciences, BioCrossroads and the IU Office of the Vice President for Engagement.
Following registration and networking from 8 to 9 a.m., Kem Hawkins, president of Cook Group Inc., will offer introductory comments. Dan Peterson, vice president for industry and government affairs of Cook Group Inc., will introduce the morning keynote speaker, Scott Gottlieb, resident fellow at the American Institute for Public Policy Research. Gottlieb will speak on the topic, "What is Comparative Effectiveness and What are the Key Policy Issues?"
A panel, "The Policy Path for Comparative Effectiveness," will follow at 10:15 a.m. and will be moderated by Peterson. The panel will include Jim Gardner, medical science officer/director of reimbursement at Cook Group Inc.; Peter Schwarz, facility investigator at the IU Center for Bioethics and an assistant professor in the IU School of Medicine; and Neil Pickett, director of health policy research and analysis at Clarian Health.
Speaking at lunch at noon, Neal Roach, a partner in Taft Stettinius and Hollister LLP, will introduce Paul Keckley, executive director of the Deloitte Center for Health Solutions, who will speak on the topic, "Perspectives from Abroad -- Uses of Comparative Effectiveness Outside of the United States."
At 1:30 p.m., a panel of executives will discuss comparative effectiveness' expected impacts on Indiana life science companies. Panelists will include William R. Cast, chief executive officer of NoMoreClipboard; Greg Odle, executive vice president and general manager of OrthoPediatrics; Marc L. Berger, vice president for global health outcomes at Eli Lilly and Co.; John Kansky, vice president for business development of Indiana Health Information Exchange; and Paul H. Van cleave, vice president for operations in SIHO Insurance Services' s Bloomington regional office. Todd Pedersen, vice president for corporate development at AIT Laboratories, will moderate.
At 3:15 p.m., the day's discussions will wrap up.
The Nov. 13 conference is sponsored by Cook Medical, the IU Johnson Center for Entrepreneurship and Innovation, Taft Stettinius and Hollister LLP, with AIT Laboratories as a supporting sponsor.
Series sponsors are the IU Kelley Center for the Business of Life Sciences, BioCrossroads and the IU Office of the Vice President for Engagement. Other financial sponsors are Baker and Daniels LLP, Barnes and Thornburg LLP; Beckman Coulter, Inc.; Clarian Health Ventures, Inc.; Commisioning Agents Inc, DePuy Orthopaedics, Eli Lilly and Co., Ice Miller LLP, Indiana University Clinical and Translational Sciences Institute; IU School of Medicine; Paragon Medical Inc., Purdue University; Symmetry Medical Inc., the University of Notre Dame and Zimmer.
Brochure and marketing sponsors are Cabello Associates, Inc.; Covidien Imaging Solutions; Bloomington Life Sciences Partnership, Indiana Health Industry Forum; IU College of Arts and Sciences; IU School of Informatics; IU Research and Technology Corp.; the Kelley School's Evening MBA Program; Methodist Medical Center of Illinois and the Northeast Indiana Innovation Center.